Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 20, 2023
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
Thomas Shrader Maintained (VRNA) at Strong Buy with Increased Target to $31 on, Mar 20th, 2023
Thomas Shrader of BTIG, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $26 to $31 on, Mar 20th, 2023.
Thomas has made no other calls on VRNA in the last 4 months.
There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Thomas's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Thomas
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Monday, March 13th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, December 20th, 2022
